Human Cytochrome b5 Requires Residues E48 and E49 to Stimulate the 17,20-Lyase Activity of Cytochrome P450c17
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Cytochrome P450c17 (CYP17) catalyzes both the 17alpha-hydroxylase and 17,20-lyase reactions in human steroid biosynthesis. Cytochrome b5 (b5) stimulates the rate of the 17,20-lyase reaction 10-fold with little influence on 17alpha-hydroxylase activity. Studies with apo-b5 suggest that stimulation of 17,20-lyase activity results from an allosteric action on the hCYP17 x POR complex, rather than electron transfer by b5. We hypothesized that specific residues on b5 interact with the hCYP17 x POR complex and that targeted mutation of surface-exposed residues might identify b5 residues critical for stimulating 17,20-lyase activity. We constructed, expressed, and purified 14 single plus 3 double b5 mutations and assayed their ability to stimulate 17,20-lyase activity. Most mutations did not alter the capacity of b5 to stimulate 17,20-lyase activity or appeared to modestly alter the affinity of b5 for the hCYP17 x POR complex. In contrast, mutation of E48, E49, or R52 reduced the maximal stimulation of 17,20-lyase activity. In particular, b5 mutation E48G + E49G lost over 95% of the capacity to stimulate 17,20-lyase activity, yet this mutation retained normal electron transfer properties. In addition, mutation E48G + E49G did not impair stimulation of 17,20-lyase activity by wild-type b5, suggesting that the mutation binds poorly to the site of the hCYP17 x POR complex occupied by b5. These data suggest that a specific allosteric binding site on b5, which includes residues E48, E49, and possibly R52, mediates the stimulation of 17,20-lyase activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Mansouri, A., & Lurie, A. A. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830420104 · Cited by 330
Bridges, A., Gruenke, L., Chang, Y.-T., Vakser, I. A., Loew, G., & Waskell, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.17036 · Cited by 287
Flück, C. E., Miller, W. L., & Auchus, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030143 · Cited by 173
Self-citationRegulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17
Pandey, A. V., & Miller, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414673200 · Cited by 165
Lee-Robichaud, P., Wright, J. N., Akhtar, M. E., & Akhtar, M. (1995) · Biochemical Journal · doi:10.1042/bj3080901 · Cited by 145
Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17
Pandey, A. V., Mellon, S. H., & Miller, W. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209527200 · Cited by 137
Sherbet, D. P., Tiosano, D., Kwist, K. M., Hochberg, Z., & Auchus, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307586200 · Cited by 131
Self-citationvan den Akker, E. L. T., Koper, J. W., Boehmer, A. L. M., Themmen, A. P. N., Verhoef-Post, M., Timmerman, M. A., Otten, B. J., Drop, S. L. S., & De Jong, F. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011880 · Cited by 125
Research works printed but not linked: 22
- Nakajin S., 1981, Biochemistry 20, 4037−4042.
- Geller D. H., 1997, Nat. Genet. 17, 201−205.
- Lee-Robichaud P., 1999, Biochem. J., 342, 10.1042/bj3420309 · doi:10.1042/bj3420309 · Paper page
- Auchus R. J., 1999, Mol. Endocrinol. 13, 1169−1182.
- Zhang L., 1995, Proc. Natl. Acad. Sci. U.S.A. 92
- Yanagibashi K., 1986, J. Biol. Chem., 261
- Flück C. E., 2004, Nat. Genet. 36, 228−230.
- Arlt W., 2004, Lancet 363, 2128−2135.
- Katagiri M., 1995, Arch. Biochem. Biophys. 317, 343−347.
- Mapes S., 1999, J. Clin. Endocrinol. Metab., 84
- Suzuki T., 2000, Clin. Endocrinol. (Oxford) 53, 739−747.
- Guryev O. L., 2001, Biochemistry 40, 5018−5031.
- Yoo M., 1988, Biochem. Biophys. Res. Commun. 156, 576−580.
- Mulrooney S. B., 2004, Biochim. Biophys. Acta, 1674
- Ren Y., 2004, Biochemistry 43, 3527−3536.
- Shao W., 2003, Biochemistry 42, 14774−147784.
- Mulrooney S. B., 2000, Protein Expression Purif. 19, 173−178.
- Gupta M. K., 2001, J. Clin. Endocrinol. Metab., 86
- Schenkman J. B., 2003, Pharmacol. Ther. 97, 139−152.
- Auchus R. J., 2001, Endocrinol. Metab. Clin. North Am. 30, 101−119.
- Yang W. H., 2005, J. Biol. Chem., 280
- Abbreviations, cytochrome b5
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationSteroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 229
Self-citationThe syndrome of 17,20 lyase deficiency
Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2161 · Cited by 143
Gilep, A. A., Sushko, T. A., & Usanov, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.021 · Cited by 145
A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)
Akhtar, M., Wright, J. N., & Lee-Robichaud, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.003 · Cited by 131
Structures of human steroidogenic cytochrome P450 17A1 with substrates
Petrunak, E. M., DeVore, N. M., Porubsky, P. R., & Scott, E. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610998 · Cited by 119
“The anionic Glu(48) and Glu(49) residues of cytochrome b5 are known to interact with the cationic Arg(347), Arg(358), and Arg(449) CYP17A1 residues based on both mutagenesis and recent solution NMR binding studies (31, 51).”
BackgroundThe diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1)
Yoshimoto, F. K., & Auchus, R. J. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.026 · Cited by 122
Self-citationAdrenocortical zonation, renewal, and remodeling
Pihlajoki, M., Dörner, J., Cochran, R. S., Heikinheimo, M., & Wilson, D. B. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00027 · Cited by 114
A Model of the Membrane-bound Cytochrome b5-Cytochrome P450 Complex from NMR and Mutagenesis Data
Ahuja, S., Jahr, N., Im, S., Vivekanandan, S., Popovych, N., Clair, S. V. L., Huang, R., Soong, R., Xu, J., Yamamoto, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448225 · Cited by 117
“A double cytb5 mutant E48G and E49G mutant (which introduced a very flexible sequence of four glycine residues) has been shown to be deficient in its ability to stimulate the activity of cytP450c17 (74).”
BackgroundIsolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
“More recently Naffin-Olivos and Auchus (25) showed that residues E48 and E49 of CytB5, located in the core domain of the protein, are also required to stimulate 17,20-lyase activity of P450c17 using targeted mutation of surface-specific residues.”
BackgroundIdkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Substrate-modulated Cytochrome P450 17A1 and Cytochrome b5 Interactions Revealed by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468926 · Cited by 100
Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
Ferraldeschi, R., Sharifi, N., Auchus, R. J., & Attard, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0931 · Cited by 93
Self-citationDeletion of Microsomal Cytochrome b5 Profoundly Affects Hepatic and Extrahepatic Drug Metabolism
McLaughlin, L. A., Ronseaux, S., Finn, R. D., Henderson, C. J., & Wolf, C. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064246 · Cited by 81
“A particularly well characterized role for cytochrome b5 is in steroid hormone biosynthesis, in which it enhances the lyase activity of Cyp17 through an allosteric mechanism but has little effect on the hydroxylase activity (Auchus et al., 1998; Akhtar et al., 2005; Naffin-Olivos and Auchus, 2006).”
BackgroundTiosano, D., Knopf, C., Koren, I., Levanon, N., Hartmann, M. F., Hochberg, Z., & Wudy, S. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0712 · Cited by 71
Electron Transfer Partners of Cytochrome P450
Waskell, L. A., & Kim, J. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_2 · Cited by 87
Salvador, J. A. R., Pinto, R. M. A., & Silvestre, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.006 · Cited by 82
Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes
Bart, A. G., & Scott, E. E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000220 · Cited by 64
“Insights into individual P450/b5 complexes gained from mutagenesis (3, 4), chemical modification (5), and cross-linking”
BackgroundResultInfluentialThe Role of Protein-Protein and Protein-Membrane Interactions on P450 Function
Scott, E. E., Wolf, C. R., Otyepka, M., Humphreys, S. C., Reed, J. R., Henderson, C. J., McLaughlin, L. A., Paloncýová, M., Navrátilová, V., Berka, K., et al. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068569 · Cited by 55
“…structures for human P450 proteins interacting with these protein partners, although mutagenesis, crosslinking, in silico docking, and other techniques have provided substantial information (Bridges et al., 1998; Naffin-Olivos and Auchus, 2006; Im and Waskell, 2011; Zhao et al., 2012).”
BackgroundBhatt, M. R., Khatri, Y., Rodgers, R. J., & Martin, L. L. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.033 · Cited by 63
Rendic, S. P., & Guengerich, F. P. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1483401 · Cited by 61
The Physiology and Biochemistry of Adrenarche
Auchus, R. J. (2010) · Endocrine development · doi:10.1159/000321209 · Cited by 55
Self-citationThe post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“The E48 and E49 residues required for the stimulation of 17,20 lyase activity (Naffin-Olivos and Auchus, 2006) are absent in the patient with W27X, but present in the patient with H44L.”
BackgroundPeng, H.-M., Im, S.-C., Pearl, N. M., Turcu, A. F., Rege, J., Waskell, L., & Auchus, R. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00532 · Cited by 50
Self-citationStructural insights into the function of steroidogenic cytochrome P450 17A1
Yadav, R., Petrunak, E. M., Estrada, D. F., & Scott, E. E. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.035 · Cited by 45
“The anionic b5 residues E48 and E49 were initially identified by mutagenesis (Naffin-Olivos and Auchus, 2006) and further confirmed by a two dimensional NMR binding study (Estrada et al.”
BackgroundKurnaz, E., Baykan, E. K., Türkyılmaz, A., Yaralı, O., Abalı, Z. Y., Turan, S., Bereket, A., Çayır, A., & Güran, T. (2020) · Hormone Research in Paediatrics · doi:10.1159/000515079 · Cited by 48
Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677294 · Cited by 47
“The two different substrates were previously found to modulate the CYP17A1 conformation (18) and CYP17A1 [(15)N]b5 interaction differently (23).”
BackgroundEvidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis
Duggal, R., Liu, Y., Gregory, M. C., Denisov, I. G., Kincaid, J. R., & Sligar, S. G. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.043 · Cited by 45
Simonov, A. N., Holien, J. K., Yeung, J. C. I., Nguyen, A. D., Corbin, C. J., Zheng, J., Kuznetsov, V. L., Auchus, R. J., Conley, A. J., Bond, A. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141252 · Cited by 43
Self-citationZhao, C., Gao, Q., Roberts, A. G., Shaffer, S. A., Doneanu, C. E., Xue, S., Goodlett, D. R., Nelson, S. D., & Atkins, W. M. (2012) · Biochemistry · doi:10.1021/bi301069r · Cited by 42
Making water-soluble integral membrane proteins in vivo using an amphipathic protein fusion strategy
Mizrachi, D., Chen, Y., Liu, J., Peng, H., Ke, A., Pollack, L., Turner, R. J., Auchus, R. J., & DeLisa, M. P. (2015) · Nature Communications · doi:10.1038/ncomms7826 · Cited by 39
Self-citationCatalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5
Peng, H., Liu, J., Forsberg, S. E., Tran, H. T., Anderson, S. M., & Auchus, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608919 · Cited by 42
“Site-directed Mutagenesis of b5 Residues Glu-48 and Glu49 —Previous work has identified the acidic residues Glu-48 and Glu-49 as critical b5 residues for stimulation of 17,20-lyase activity (6, 7).”
BackgroundMethodSelf-citationP450 Enzymes in Steroid Processing
Auchus, R. J., & Miller, W. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_12 · Cited by 44
Self-citationYoshimoto, F. K., Zhou, Y., Peng, H.-M., Stidd, D., Yoshimoto, J. A., Sharma, K. K., Matthew, S., & Auchus, R. J. (2012) · Biochemistry · doi:10.1021/bi300895w · Cited by 38
Self-citationCytochrome b5: Novel roles in steroidogenesis
Storbeck, K., Swart, A. C., Goosen, P., & Swart, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.11.020 · Cited by 45
“Indeed, it has been suggested that residues Glu48 and Glu49 may form part of an allosteric binding site responsible for mediating the stimulation of CYP17A1 lyase activity (Naffin-Olivos and Auchus 2006).”
Functional expression and characterisation of human cytochrome P45017α in Pichia pastoris
Kolar, N. W., Swart, A. C., Mason, J. I., & Swart, P. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.02.003 · Cited by 46
Cytochrome b5 modulates multiple reactions in steroidogenesis by diverse mechanisms
Storbeck, K., Swart, A. C., Fox, C.-L., & Swart, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.024 · Cited by 36
Nguyen, A. D., Corbin, C. J., Pattison, J. C., Bird, I. M., & Conley, A. J. (2008) · Endocrinology · doi:10.1210/en.2008-1303 · Cited by 36
Wang, Y.-H., Tee, M. K., & Miller, W. L. (2010) · Endocrinology · doi:10.1210/en.2009-1247 · Cited by 31
“The residues of b5 that interact with P450c17 to promote lyase activity have been mapped by mutagenesis to E48 and E49 (25), but the corresponding interacting sites on P450c17 have not been reported, although detailed mapping of CYP2B4 identified seven sites that interact with b5, six of which are on the proximal face…”
BackgroundAcyl-Carbon Bond Cleaving Cytochrome P450 Enzymes: CYP17A1, CYP19A1 and CYP51A1
Akhtar, M., & Wright, J. N. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_4 · Cited by 30
“tion of cytochrome b5 had shown that the substitution of Glu and Glu with Gly generated mutants that showed decreased activity to stimulate the side-chain cleaving activity of CYP17A1 [76].”
BackgroundThe Action of Cytochromeb5on CYP2E1 and CYP2C19 Activities Requires Anionic Residues D58 and D65
Peng, H., & Auchus, R. J. (2012) · Biochemistry · doi:10.1021/bi301384n · Cited by 28
Self-citationInsights into Interactions of Human Cytochrome P450 17A1: A Review
Singh, H., Kumar, R., Mazumder, A., Salahuddin, S., Mazumder, R., & Abdullah, M. M. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220401093833 · Cited by 37
Peng, H., & Auchus, R. J. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00034 · Cited by 26
Self-citationCorrelating Structure and Function of Drug-Metabolizing Enzymes: Progress and Ongoing Challenges
Johnson, E. F., Connick, J. P., Reed, J. R., Backes, W. L., Desai, M. C., Xu, L., Estrada, D. F., Laurence, J. S., & Scott, E. E. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054627 · Cited by 27
“The b5 mutations E48G and E49G are known to decrease the ability of b5 to stimulate the CYP17A1 lyase activity without negatively affecting the b5-insensitive hydroxylase reaction (Naffin-Olivos and Auchus, 2006).”
BackgroundSteroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Gonzales, G. F., & Chaupis-Meza, D. (2014) · Andrologia · doi:10.1111/and.12359 · Cited by 26
“Cytochrome b5 stimulated the lyase activity by up to 10-fold with little influence on 17 alpha-hydroxylase activity (Akhtar et al., 2005; Naffin-Olivos & Auchus, 2006).”
BackgroundGleicher, N., Darmon, S. K., Molinari, E., Zhang, L., Hu, J., Albertini, D. F., & Barad, D. H. (2020) · Endocrine · doi:10.1007/s12020-020-02512-0 · Cited by 21
Mahajan, M. K., Ravula, T., Prade, E., Anantharamaiah, G. M., & Ramamoorthy, A. (2019) · Chemical Communications · doi:10.1039/c9cc01630a · Cited by 19
Röhrig, T., Pihlajoki, M., Ziegler, R., Cochran, R. S., Schrade, A., Schillebeeckx, M., Mitra, R. D., Heikinheimo, M., & Wilson, D. B. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.003 · Cited by 19
“It is conceivable that human GATA6 haploinsufficiency is associated with a subtle adrenal phenotype such as impaired fetal zone development or reduced DHEA(-”
BackgroundInfluentialImpaired 17,20-Lyase Activity in Male Mice Lacking Cytochrome b5 in Leydig Cells
Sondhi, V., Owen, B. M., Liu, J., Chomic, R., Kliewer, S. A., Hughes, B. A., Arlt, W., Mangelsdorf, D. J., & Auchus, R. J. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1282 · Cited by 19
“Enzyme assay 156 Recombinant tetrahistidine-tagged human b5 was prepared as described (27).”
MethodSelf-citationDuarte, M. P., Palma, B. B., Gilep, A. A., Laires, A., Oliveira, J. S., Usanov, S. A., Rueff, J., & Kranendonk, M. (2006) · Mutagenesis · doi:10.1093/mutage/gel054 · Cited by 17
Effect of mutations in porcine CYB5A and CYP17A1 on the metabolism of pregnenolone
Squires, E. J., Gray, M. A., & Lou, Y. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105469 · Cited by 14
Peng, H., & Auchus, R. J. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.11.001 · Cited by 13
Self-citationAuchus, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00008-9 · Cited by 15
Self-citationTateishi, Y., Webb, S. N., Li, B., Liu, L., Rose, K. L., Leser, M., Patel, P. R., & Guengerich, F. P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105688 · Cited by 8
Cytochrome b5 Binds Tightly to Several Human Cytochrome P450 Enzymes
Kim, D., Kim, V., Tateishi, Y., & Guengerich, F. P. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000475 · Cited by 7
Steroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic
Salvador, J. A. R., Vania, M., & Silvestre, S. (2013) · InTech eBooks · doi:10.5772/52290 · Cited by 10
Yamagata, S., Kageyama, K., Usui, T., Saito, K., Takayasu, S., Usutani, M., Terui, K., & Daimon, M. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0266 · Cited by 7
“Because the redox partner interaction domain is essential for the 17α-hydroxylase/17,20-lyase function of P450c17, this mutation modulates the 17αhydroxylase/17,20-lyase enzymatic activities by weaken‐ ing the binding of P450-oxidoreductase (OR) and cytochrome b5 [10, 24-31].”
BackgroundYantsevich, А. V., Harnostai, I. N., Lukashevich, O. P., Gilep, A. A., & Usanov, S. A. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907010099 · Cited by 5
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Self-citationJaffey, J. A., Struthers, J. D., Yuh, E. L., Hostnik, E. T., Runyan, R. A., & Reading, N. S. (2022) · Topics in companion animal medicine · doi:10.1016/j.tcam.2022.100649 · Cited by 1
17α-Hydroxylase/17,20-Lyase Deficiency
Auchus, R. J., & Miller, W. L. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00631-4
Self-citationAn investigation into the catalytic activity of porcine cytochrome P450 17α-hydroxylase/17,20-lyase
Fox, C.-L. (2014) · SUNScholar (Stellenbosch University)
Functional and Structural Studies of Cytochromes P450 by Resonance Raman Spectroscopy
Liu, Y. (2017) · e-Publications@Marquette (Marquette University)
17α-Hydroxylase/17, 20-Lyase Deficiency☆
Auchus, R. J., & Miller, W. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04129-5
Self-citationPolycystic Ovary Syndrome in the Peripubertal Period
Witchel, S. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_13
Metadata
- Authors
- Naffin-Olivos, J. L., & Auchus, R. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Auchus, Richard J.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-12-27
- Volume
- 45
- Issue
- 3
- Pages
- 755-762
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2020954599
- Semantic Scholar
- 9199c6c6e03db9d9c67d7be61637135b21bc1c58
- Cited by
- 66
- References
- 18
- Citations by year
- 2024: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 7 · 2015: 8 · 2014: 10 · 2013: 7 · 2012: 4
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK59942, R21DK059942)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32 HD07190, T32HD007190)
- Topics
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- cytochrome b5, P450c17, 17,20-lyase activity, 17α-hydroxylase, steroidogenesis, allosteric regulation, protein-protein interaction, electron transfer, site-directed mutagenesis
- MeSH terms
- Binding Sites, Cell Line, Humans, Lyases, Models, Molecular, Steroid 17-alpha-Hydroxylase, Structure-Activity Relationship, Substrate Specificity, Cytochromes b5, Point Mutation, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.